Reviva Pharmaceuticals Holdings, Inc. Profile Avatar - Palmy Investing

Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardio…

Biotechnology
US, Cupertino [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Reviva Pharmaceuticals Holdings, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of RVPH's Analysis
CIK: 1742927 CUSIP: 76152G100 ISIN: US76152G1004 LEI: - UEI: -
Secondary Listings
RVPH has no secondary listings inside our databases.